Show simple item record

dc.contributor.authorYlönen Susanna
dc.contributor.authorSiitonen Ari
dc.contributor.authorNalls Michael A
dc.contributor.authorYlikotila Pauli
dc.contributor.authorAutere Jaana
dc.contributor.authorEerola-Rautio Johanna
dc.contributor.authorGibbs Raphael
dc.contributor.authorHiltunen Mikko
dc.contributor.authorTienari Pentti J
dc.contributor.authorSoininen Hilkka
dc.contributor.authorSingleton Andrew B
dc.contributor.authorMajamaa Kari
dc.date.accessioned2018-01-18T13:15:25Z
dc.date.available2018-01-18T13:15:25Z
dc.date.issued2017
dc.identifier.urihttps://erepo.uef.fi/handle/123456789/5192
dc.description.abstractIntroduction Variation contributing to the risk of Parkinson's disease (PD) has been identified in several genes and at several loci including GBA, SMPD1, LRRK2, POLG1, CHCHD10 and MAPT, but the frequencies of risk variants seem to vary according to ethnic background. Our aim was to analyze how variation in these genes contributes to PD in the Finnish population. Methods The subjects consisted of 527 Finnish patients with early-onset PD, 325 patients with late-onset PD and 403 population controls. We screened for known genetic risk variants in GBA, SMPD1, LRRK2, POLG1, CHCHD10 and MAPT. In addition, DNA from 225 patients with early-onset Parkinson's disease was subjected to whole exome sequencing (WES). Results We detected a significant difference in the length variation of the CAG repeat in POLG1 between patients with early-onset PD compared to controls. The p.N370S and p.L444P variants in GBA contributed to a relative risk of 3.8 in early-onset PD and 2.5 in late-onset PD. WES revealed five variants in LRRK2 and SMPD1 that were found in the patients but not in the Finnish ExAC sequences. These are possible risk variants that require further confirmation. The p.G2019S variant in LRRK2, common in North African Arabs and Ashkenazi Jews, was not detected in any of the 849 PD patients. Conclusions The POLG1 CAG repeat length variation and the GBA p.L444P variant are associated with PD in the Finnish population.en
dc.language.isoENen
dc.publisherElsevier BVen
dc.relation.ispartofseriesPARKINSONISM & RELATED DISORDERSen
dc.relation.urihttp://dx.doi.org/10.1016/j.parkreldis.2017.09.021en
dc.rightsCC BY-NC-ND 4.0
dc.subjectMolecular epidemiologyen
dc.subjectNeurodegenerative diseasesen
dc.subjectMutationen
dc.subjectMitochondrialen
dc.subjectGeneen
dc.titleGenetic risk factors in Finnish patients with Parkinson's diseaseen
dc.description.versionfinal draften
dc.contributor.departmentSchool of Medicine / Clinical Medicineen
uef.solecris.id50260270en
dc.type.publicationinfo:eu-repo/semantics/articleen
dc.relation.doi10.1016/j.parkreldis.2017.09.021en
dc.description.reviewstatuspeerRevieweden
dc.format.pagerange39-43en
dc.relation.issn1353-8020en
dc.relation.volume45en
dc.rights.accesslevelopenAccessen
dc.type.okmA1en
dc.type.versioninfo:eu-repo/semantics/acceptedVersionen
uef.solecris.openaccessEi
dc.rights.copyright© Elsevier Inc.
dc.type.displayTypearticleen
dc.type.displayTypeartikkelifi
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record